SAM
AMED

Sawgrass Asset Management’s Amedisys AMED Stock Holding History

Sawgrass Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-885
Closed -$209K – 168
2020
Q3 		$209K Buy
+885
New +$201K 0.02% 150
2019
Q2 		– Sell
-2,225
Closed -$274K – 168
2019
Q1 		$274K Sell
2,225
-1,185
-35% -$149K 0.01% 187
2018
Q4 		$399K Buy
+3,410
New +$402K 0.02% 154
2017
Q4 		– Sell
-4,610
Closed -$258K – 210
2017
Q3 		$258K Sell
4,610
-12,070
-72% -$638K 0.01% 190
2017
Q2 		$1.05M Buy
+16,680
New +$971K 0.05% 100

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sawgrass Asset Management's AMED Position: Q4 2020 in Review

Sawgrass Asset Management sold out of Amedisys (AMED) in Q4 2020, closing a stake of 885 shares — an estimated $209K sold.

Sawgrass Asset Management first reported a position in AMED in Q2 2017 and held it in 5 quarters. The position peaked at $1.05M in Q2 2017. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Sawgrass Asset Management reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Sawgrass Asset Management sold 885 Amedisys shares in Q4 2020, an estimated $209K.
  • Sawgrass Asset Management first reported a position in Amedisys in Q2 2017 and held it in 5 quarters.
  • Sawgrass Asset Management's Amedisys position peaked at $1.05M in Q2 2017.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Sawgrass Asset Management's 13F filing for Q4 2020, filed 22 Jan 2021.